Accelerating pharma impact with AI-powered digital health
Family-centered digital companions and AI agents for pediatric chronic care - advancing RWE and post-marketing success
RWE & evidence generation
Capture meaningful behavioral, emotional, and treatment adherence data - validated across multiple pediatric chronic therapeutic areas.
Digital health differentiation
Offer a digital companion that supports families 24/7 while extending the impact of your therapy.
Precision engagement
Leverage behavioral science + responsible AI to activate and retain patients and caregivers over time.
Built for RWE. Designed for families. Driven by science.
Flexible models to support your goals
Investigator-Initiated Studies (ISS) & co-development
Collaborate with KOLs to develop condition-specific digital companions or validate clinical endpoints.
Commercial launch support
Boost post-marketing differentiation, generate digital engagement metrics, and drive brand loyalty.
Lifecycle management
Deploy updates and new modules to evolve with the science - and family needs.
Proven across leading pharma companies
Merck KGaA
Chronic Condition: Pediatric Growth Hormone Disorders
Key Results
Reduced caregiver distress
Improved perceived competence
Increased treatment engagement
Increased quality of life
Presentations
ESPE 2022
ISPAD 2024
ENDO 2025
Publications
AbbVie
Chronic Condition: Rheumatology
Key Results
Positive engagement and meaningful capture of patient reported outcomes (PROs) to support personalized care
Presentations
EULAR
American College of Rheumatology
Spanish Society of Rheumatology
Publications
The Annals of the Rheumatic Diseases
Novo Nordisk
Chronic Condition: Pediatric Type 1 Diabetes
Key Results
Hyperglycemia linked to caregiver depression and poor child academic outcomes
Nighttime hypoglycemia impacted social and school functioning
Caregiver education improved glycemic control
Presentations
ADA 2023
ISPAD 2024
ENDO 2025
Publications
Roche
Chronic Condition: Oncology
Key Results
Partnership with 10 oncology centers enhancing ways to evaluate performance status
Presentations
2022 ASCO Annual Meeting
2020 World Conference on Lung Cancer
Publications
JCO Clinical Cancer Informatics
A new standard in pharma - grade digital health
AI + Human touch (Wellness Coaches)
Modular, multilingual platform
Customizable per therapy or population
Designed with regulatory foresight (FDA General Wellness)
Pediatric + Family behavioral science focus
Explore what’s possible together
Let’s co-create the next generation of digital health experiences that support your pediatric chronic care therapy -
and the families who rely on it.